Brown, Lisle/Cummings’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
2,863
+129
+5% +$65.3K 0.33% 77
2025
Q4
$1.55M Buy
2,734
+110
+4% +$58.6K 0.38% 63
2025
Q3
$1.17M Buy
2,624
+60
+2% +$28.8K 0.3% 84
2025
Q2
$1.39M Buy
2,564
+140
+6% +$73.2K 0.37% 66
2025
Q1
$1.2M Buy
2,424
+562
+30% +$311K 0.35% 72
2024
Q4
$972K Buy
1,862
+266
+17% +$139K 0.29% 83
2024
Q3
$784K Buy
1,596
+240
+18% +$112K 0.24% 99
2024
Q2
$603K Buy
1,356
+631
+87% +$251K 0.2% 114
2024
Q1
$289K Hold
725
0.1% 170
2023
Q4
$245K Hold
725
0.09% 179
2023
Q3
$212K Hold
725
0.1% 173
2023
Q2
$248K Hold
725
0.11% 161
2023
Q1
$185K Hold
725
0.09% 175
2022
Q4
$192K Hold
725
0.1% 163
2022
Q3
$136K Hold
725
0.08% 180
2022
Q2
$146K Buy
725
+365
+101% +$85.6K 0.08% 183
2022
Q1
$109K Hold
360
0.05% 206
2021
Q4
$129K Buy
+360
New +$124K 0.06% 194

Other funds holding ISRG

Brown, Lisle/Cummings's ISRG Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Intuitive Surgical (ISRG) stake by 4.7% in Q1 2026, buying an estimated $65.3K and bringing the position to 2,863 shares worth $1.32M. The position accounts for 0.33% of the portfolio, ranked #77.

Brown, Lisle/Cummings first reported a position in ISRG in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.55M in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Brown, Lisle/Cummings held 2,863 shares of Intuitive Surgical worth $1.32M as of Q1 2026.
  • Brown, Lisle/Cummings bought 129 Intuitive Surgical shares in Q1 2026, an estimated $65.3K.
  • Intuitive Surgical made up 0.33% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #77 holding.
  • Brown, Lisle/Cummings first reported a position in Intuitive Surgical in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Intuitive Surgical position peaked at $1.55M in Q4 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.